Does Private Equity Work in Cardiology? US Heart & Vascular's Integration Play | Claims Denied

Featuring Emily Rash (COO) and Dr. Neil Gheewala (CMO of Value-Based Care), US Heart and Vascular --- 3-6 weeks. That's the national average wait time to see a cardiologist — and it's exactly the inefficiency Emily and Neil are betting they can fix. Blake Madden sits down with them for a candid conversation on what actually separates an integrated cardiology platform from practices just bolted onto a cap table. Topics covered include: The Ares + Rubicon Founders dual capital structure — one of the sharpest specialty-VBC sponsor pairings out there The "AIR" framework (autonomy, independence, representative governance) — and why the third leg is where most rollups fail Why cardiology may be the cleanest specialty fit for value-based care (no structural fee-for-service conflict like a hospital has) Neil's actual pitch to RFK Jr. for a "Level 6" reimbursement category for ambulatory IV diuretics Where cardiology bifurcates over the next five years: outpatient access groups vs. hospital-based acute care If specialty VBC, physician governance, or the cardiology rollup wave is on your radar, this one's a must-watch! --- Navvis partners with health systems and health plans to deliver real performance improvement across value-based care and fee-for-service models. ⁠https://navvishealthcare.com/vbc⁠ --- For expert analysis on healthcare M&A, strategy, finance, and markets, join 68K+ readers of Blake Madden’s Hospitalogy newsletter. Subscribe here: ⁠⁠⁠⁠https://hospitalogy.com/⁠⁠⁠⁠ Like the Claims Denied Podcast? Check out the Hospitalogy YouTube Channel for previous episodes    / @hospitalogy   Be sure to Subscribe, leave a comment, and share Claims Denied with your healthcare colleagues.